Summary as of Wednesday 17th January 2024

Happy New Year to all our readers!

Future research and recruitment

Thank you for your continued involvement in user research – your participation is integral to understanding the user experience on ASPeL.

We are planning to restart the research on the Named Persons journey in the New Year. If you are interested in taking part in this work, or any future work related to ASPeL, please contact Rachel Cholerton, Senior User Researcher, at rachel.cholerton@digital.homeoffice.gov.uk.

Don’t forget to check out our roadmap to see what’s coming next to ASPeL.

No machine-readable author provided. Sepht~commonswiki assumed (based on copyright claims)., CC BY-SA 3.0 <http://creativecommons.org/licenses/by-sa/3.0/>, via Wikimedia Commons/3.0/>, via Wikimedia Commo.

The Tapir interesting fact: The tapir can grow up to 2m and is an excellent swimmer.

Completed this Sprint: 139 (Tapir)

1) Add a filter on task list screen for the Category E licence applications 2) Update ROPs permissible purposes for education and training 3) ROPs Show and Tell for all 4) Research in preparation for Named people feature

Bugs Fixed this Sprint

There were no bugs fixed this Sprint. Please bear with us as we improve on development capacity within the team.

New Sprint: 140 (Uakari)

Evgenia Kononova, upload on en:wiki by user Ipaat on en.wikipedia, Public domain, via Wikimedia Commons

Uakari fun and interesting facts: The Uakari is characterized by a bright crimson face and a very short tail.

Planned for Sprint 140 (Uakari)

1) Complete the Pipeline upgrade 2) Finish writing the PIL E development tickets 3) Fully scope the Named People work 4) Fix the Resuable Steps bugs 5) Map out work to get the Keeping animals alive feature ready for development 6) Fully Onboard the new developer and the new Product Manager.

Things to bear in mind

Let us know how we are doing in keeping you informed. We appreciate your feedback on the content of this report.

Work in progress

1) Update the anitbody generation conditions for all PPL applications using antibody testing. 2) Harm Benefit Upload transfer journey 3) Intention to Refuse improvement for all licences

Support tickets and known issues

Link to Support Board